Key individuals include Ryan Nagim (LVC Managing Partner and Head of Healthcare), Austin Rees (LVC Partner), Paul Swaney (SGC Managing Partner), Bill Braun (new operating partner and executive chairman, ex-CEO/President of DDS Lab), Kay Hayden (Apex President and Co-Founder), and Travis Zick (Apex M&A Director and Co-Founder)[2][6][7][9]. LVC and SGC will collaborate with Apex's retained management to drive growth via organic expansion, acquisitions, technology investments, operational efficiencies, and scaling its U.S.-made restoration platform[2][6][7][9][10].
Apex grew through 3 de novo lab openings and 22 acquisitions, establishing a national footprint and innovation edge in dental labs supporting practices and patient outcomes[6][7][9]. The deal, advised by BGL, reflects prior momentum in a consolidating industry[2][9].
Newsworthy amid rising private equity interest in dental labs for scale, efficiencies, and innovation; announced just over a week ago (March 31, 2026), it highlights LVC's healthcare portfolio expansion and industry trends toward domestic manufacturing and digital advancements[1][2][5][7].